Rhj Begent

Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 C

Christilyn Graff, Kerry Chester, Rhj Begent et al. · Protein Engineering Design and Selection · 2004 · 139 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies

D. J. Lane, K Eagle, Rhj Begent et al. · British Journal of Cancer · 1994 · 98 citations

Medicine, Nuclear Medicine, Oncology +17

Bone disease in testicular and extragonadal germ cell tumours

R. N. HITCHINS, PA Philip, B. Wignall et al. · British Journal of Cancer · 1988 · 55 citations · Full text

Medicine, Endocrinology, Oncology +12

Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis

R. N. HITCHINS, ES Newlands, DB Smith et al. · British Journal of Cancer · 1989 · 53 citations · Full text

Medicine, Oncology, Chemotherapy +6

Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models

Ethaar El‐Emir, Jason L.J. Dearling, Alexandra Huhalov et al. · British Journal of Cancer · 2007 · 37 citations · Full text

Medicine, Nuclear Medicine, Oncology +17